VivaLNK is a provider of connected healthcare devices for wellness, patient care, and telemedicine. The company’s portfolio includes wearable medical grade devices and data analytics applications that continuously monitor the health and well-being of individuals.
Our vision is to improve the quality and accessibility of healthcare worldwide by combining technology, data, and analytics into an integrated solution.
Jeffrey Olgin, MD - Prof. & Chief of Cardiology, UCSF
Dr. Jeffrey Olgin, a cardiologist and electrophysiologist, is Chief of the Division of Cardiology, and co-director of the UCSF Heart and Vascular Center. His main clinical interests include conduction disorders, arrhythmias, catheter ablation, implantable devices—pacemakers and defibrillators, atrial fibrillation, atrial flutter, ventricular tachycardia, sudden death and supraventricular tachycardia.
Vernon D. Smith, MD
Doctor Vernon Smith is board certified, specializing in Emergency Medicine. He has 13 years experience and graduated from Wake Forest University. Doctor Smith is a published author, having articles in peer reviewed journals.
Dirk Schapeler - Director Digital Health, Bayer Healthcare
Dirk Schapeler is Director Digital Health and an Intrapreneur with Bayer AG, the $55 billion global conglomerate, developing an Innovation Hub within Bayer HealthCare in Silicon Valley. He previously served as the CEO of Bayer's ViviTouch subsidiary Artificial Muscle Inc. in Sunnyvale. Dirk is passionate about innovation and technology, and their emerging role in digital health. Key areas of interest include: remote patient monitoring, Big Data, vital signs monitoring, visualisation and other medical related innovations. Dirk has brought innovative technologies from very early-stage to high-volume commercial products. Dirk is the co-inventor on numerous patents. He holds graduate degrees in Electronics and Mechanics, together with business training.